Stock Scorer

BioGaia AB (BIOG-B.ST)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in SEK. Every figure as a table ›

Revenue Annual

0 400M 800M 1.2B FY20: 747.1M FY21: 785.1M FY22: 1.1B FY20 FY21 FY22

Gross Profit Annual

0 300M 600M 900M FY20: 546.9M FY21: 582.9M FY22: 801.9M FY20 FY21 FY22

Operating Income Annual

0 150M 300M 450M FY20: 228.2M FY21: 253.7M FY22: 361.5M FY20 FY21 FY22

Net Income Annual

0 150M 300M 450M FY20: 179.7M FY21: 196.3M FY22: 373.8M FY20 FY21 FY22

Operating Cash Flow Annual

0 150M 300M 450M FY20: 221.3M FY21: 221.9M FY22: 318.9M FY20 FY21 FY22

Free Cash Flow Annual

0 150M 300M 450M FY20: 205.2M FY21: 215.5M FY22: 301M FY20 FY21 FY22

Operating cash flow minus capital expenditure.

EPS Annual

0.00 70.00 140.00 210.00 FY21: 194.00 FY22: 37.00 FY21 FY22

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

Not drawn for BIOG-B.ST: Cost of Revenue, Shares Outstanding. Nothing in this filer's XBRL supports them for the periods asked for. That is a gap in the filing, not a zero, and drawing a flat line would be an invention.